⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18843393 | 1.00 | ALDH1A1 (0.37) | — | |
| SCHEMBL739326 | 1.00 | — | — | |
| SCHEMBL1360 | 1.00 | — | — | |
| SCHEMBL2250577 | 1.00 | — | — | |
| Methane SCHEMBL28281172 | 0.96 | — | — | |
| Water SCHEMBL27580599 | 0.96 | — | — | |
| Bromide SCHEMBL2734598 | 0.96 | — | — | |
| SCHEMBL31371887 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL437742 | 0.96 | — | — | |
| Ammonia Solution, Strong SCHEMBL2255969 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 866 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| CN-110945418-B | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2022-04-26 | — | — | CN | claimed |
| CN-109963833-B | Process for the preparation of mono-protected alpha, omega-diaminoalkanes | 拜奥迪斯私人有限公司 | 2022-02-22 | — | — | CN | claimed |
| CN-113728270-A | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same | 日产化学株式会社 | 2021-11-30 | — | — | CN | claimed |
| EP-3172213-B1 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2021-09-22 | — | — | EP | claimed |
| EP-3538510-B1 | PROCESS FOR THE PREPARATION OF MONO-PROTECTED ALPHA,OMEGA-DIAMINO ALKANES | BYONDIS BV (NL) | 2021-01-06 | — | — | EP | claimed |
| US-10815194-B2 | Process for the preparation of mono-protected α,ω-diamino alkanes | BYONDIS B.V. (NL) | 2020-10-27 | — | — | US | claimed |
| CN-110945418-A | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2020-03-31 | — | — | CN | claimed |
| EP-3538510-A1 | PROCESS FOR THE PREPARATION OF MONO-PROTECTED alpha,omega-DIAMINO ALKANES | Synthon Biopharmaceuticals B.V. (NL) | 2019-09-18 | — | — | EP | claimed |
| EP-3068405-B1 | PYRROLO [1,2,F][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | GILEAD SCIENCES INC (US) | 2019-05-01 | — | — | EP | claimed |
| US-8076285-B2 | Lysobactin amides | AICURIS GMBH & CO. KG (DE) | 2011-12-13 | — | — | US | claimed |
| EP-2007794-B1 | LYSOBACTIN AMIDES | AICURIS GMBH & CO KG (DE) | 2011-09-14 | — | — | EP | claimed |
| EP-2178834-A1 | THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF | UNIVERSITE DE ROUEN (FR) | 2010-04-28 | — | — | EP | claimed |
| US-20090203582-A1 | LYSOBACTIN AMIDES | BAYER HEALTHCARE AG (DE) | 2009-08-13 | — | — | US | claimed |
| WO-2009043986-A1 | THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF | UNIVERSITE DE ROUEN (FR) | 2009-04-09 | — | — | WO | claimed |
| EP-2007794-A1 | LYSOBACTIN AMIDES | AiCuris GmbH & Co. KG (DE) | 2008-12-31 | — | — | EP | claimed |
| WO-2007118691-A1 | LYSOBACTIN AMIDES | AICURIS GMBH & CO. KG (DE) | 2007-10-25 | — | — | WO | claimed |
| US-6534658-B1 | Intermediates for producing pharmaceuticals | ONO PHARMACEUTICAL CO., LTD. (JP) | 2003-03-18 | — | — | US | claimed |
| US-6057096-A | NONRADIOACTIVE METHOD BY CONJUGATING LABELING AGENT TO ONE OR MORE OLIGONUCLEOTIDE PRIMERS, AMPLIFYING A NUCLEIC ACID SEQUENCE WITH PRIMERS, TREATING AMPLIFIED SEQUENCES WITH ELECTROMAGNETIC RADIATION | THE TRUSTEES OF BOSTON UNIVERSITY (US) | 2000-05-02 | — | — | US | claimed |
| US-5986076-A | A CONJUGATE IS FORMED BY BONDING A BIOREACTIVE AGENT TO THE THERAPEUTIC AGENT WITH A BOND THAT IS SELECTIVELY CLEAVABLE WITH ELECTROMAGNETIC RADIATION; USEFUL FOR CONTROLLED RELEASE OF DRUGS TO TREAT THE DISORDER | TRUSTEES OF BOSTON UNIVERSITY (US) | 1999-11-16 | — | — | US | claimed |